Epithelial Malignant Thymoma, also known as well differentiated thymic carcinoma, is related to thymic carcinoma and thymoma type b2. An important gene associated with Epithelial Malignant Thymoma is CD5 (CD5 Molecule). The drugs Lenvatinib and Pembrolizumab have been mentioned in the context of this disorder. Affiliated tissues include thymus and t cells.